Step by Stepa HemeOncBuddy patient portal

Mitoxantrone

Illustration: Mitoxantrone

Say it: mye-toe-ZAN-trone

Mitoxantrone is a chemotherapy medicine that damages the DNA of cancer cells so they cannot grow.

What it is

Mitoxantrone slips in between the strands of DNA. It also blocks an enzyme called topoisomerase II that cells need to copy DNA. This causes DNA breaks, and the cancer cells die.

Often used for

How you get it

Mitoxantrone is given through a vein (IV) over about 5 to 30 minutes. For leukemia it is often given once a day for a few days in a row. For prostate cancer it is often given every 3 weeks. Your schedule may be different.

Common side effects and what helps

Call your care team right away if you have

Before you start, tell your team

Good to know

Questions to ask

Part of these treatment plans

Side effect guides

Sources

Quick answers

What is Mitoxantrone?
Mitoxantrone is a chemotherapy medicine that damages the DNA of cancer cells so they cannot grow.
What is Mitoxantrone used for?
acute myeloid leukemia (AML); advanced prostate cancer, to ease pain; some lymphomas; certain forms of multiple sclerosis.
How is Mitoxantrone given?
Mitoxantrone is given through a vein (IV) over about 5 to 30 minutes. For leukemia it is often given once a day for a few days in a row. For prostate cancer it is often given every 3 weeks. Your schedule may be different.
What are the common side effects of Mitoxantrone?
Blue-green urine for a day or two. Low blood counts, which raise your risk of infection and bleeding. Nausea and vomiting. Mouth sores. Hair thinning or loss. Feeling tired. Missed or changed periods.
When should I call my care team while taking Mitoxantrone?
A fever of 100.4 degrees Fahrenheit (38 degrees Celsius) or higher, or chills; Shortness of breath, swelling in your legs or feet, or a fast or uneven heartbeat; Chest pain or pressure; Pain, redness, or swelling where the IV went in; Unusual bleeding or bruising; Mouth sores that keep you from eating or drinking.
Which chemotherapy plans include Mitoxantrone?
CLAG-M.

Last updated: 2026-10-27. Medically reviewed by Veli Bakalov, MD, medical oncologist (October 2026). General education from Step by Step, the patient portal of HemeOncBuddy.